Abbott Laboratories (NYSE:ABT) Q4 2024 Earnings Call Transcript

Abbott Laboratories (NYSE:ABT) Q4 2024 Earnings Call Transcript January 22, 2025

Abbott Laboratories reports earnings inline with expectations. Reported EPS is $1.34 EPS, expectations were $1.34.

Operator: Good morning and thank you for standing by. Welcome to Abbott’s Fourth Quarter 2024 Earnings Conference Call. All participants will be able to listen only until the question-and-answer portion of this call. [Operator Instructions] This call is being recorded by Abbott. With the exception...